For professionals engaged in pharmaceutical research and development, a deep understanding of the chemical building blocks used in API synthesis is essential. Baricitinib, a significant JAK inhibitor, is synthesized using specific intermediates that determine the efficiency and quality of the final product. NINGBO INNO PHARMCHEM CO.,LTD. is a leading supplier of these crucial components, including the high-quality Baricitinib intermediate: 4-(1H-Pyrazol-4-yl)-7-((2-(Trimethylsilyl)Ethoxy)Methyl-7H-Pyrrolo[2,3-d]Pyrimidine, with CAS No. 941685-27-4.

This particular intermediate is characterized by its specific molecular structure, which is vital for creating Baricitinib, a medication used to treat rheumatoid arthritis, alopecia areata, and certain forms of COVID-19. The pharmaceutical intermediate synthesis process demands absolute precision. Our company ensures that this intermediate, often supplied in liquid form, meets rigorous purity standards, typically exceeding 98%. This commitment to quality means that researchers can rely on consistent results when using our products for their synthesis needs, whether for bulk API production or early-stage research.

NINGBO INNO PHARMCHEM CO.,LTD. understands that innovation often requires bespoke solutions. Beyond our catalog of standard intermediates, we offer expert custom synthesis services. This means we can work with clients to develop and produce unique chemical compounds, including novel Baricitinib intermediates or related structures tailored to specific research objectives. Our custom synthesis approach is designed to empower researchers by providing them with the exact molecular tools required to explore new therapeutic avenues and accelerate the drug discovery timeline.

The selection of a reliable supplier for pharmaceutical intermediates is a strategic decision for any R&D team. By choosing NINGBO INNO PHARMCHEM CO.,LTD., you gain access to a partner dedicated to quality, innovation, and timely delivery. Our expertise in pharmaceutical intermediate synthesis, combined with our custom manufacturing capabilities, positions us as a valuable resource for companies aiming to bring life-changing therapies to market efficiently and effectively. We are proud to contribute to the advancement of medicine through our high-caliber chemical intermediates.